Track market-moving stories before they get noisy

Fifth Third Bancorp grew its stake in shares of American Financial Group, Inc. (NYSE:AFG – Free Report) by 264.8% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 21,579 shares of the insurance provider’s stock after buying an additional 15,663 shares during the quarter. Fifth Third Bancorp’s holdings in American Financial Group were worth $2,756,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of AFG. Charles Schwab Investment Management Inc. increased its holdings in American Financial Group by 2.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,567,721 shares of the insurance provider’s stock worth $350,956,000 after purchasing an additional 57,246 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of American Financial Group by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 1,732,557 shares of the insurance provider’s stock worth $236,645,000 after purchasing an additional 29,731 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of American Financial Group by 12.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,266,001 shares of the insurance provider’s stock valued at $173,045,000 after buying an additional 138,483 shares during the period. Northern Trust Corp increased its stake in shares of American Financial Group by 33.2% in the third quarter. Northern Trust Corp now owns 1,026,783 shares of the insurance provider’s stock valued at $149,623,000 after buying an additional 255,693 shares during the period. Finally, Morgan Stanley raised its holdings in American Financial Group by 4.3% in the 4th quarter. Morgan Stanley now owns 894,998 shares of the insurance provider’s stock valued at $122,329,000 after buying an additional 36,971 shares during the last quarter. 64.37% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In A number of analysts recently weighed in on AFG shares. Keefe, Bruyette & Woods increased their price objective on American Financial Group from $140.00 to $148.00 and gave the company a “market perform” rating in a report on Wednesday, July 8th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of American Financial Group in a report on Thursday, June 11th. Wells Fargo & Company increased their price target on American Financial Group from $158.00 to $173.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Finally, Piper Sandler lifted their price objective on American Financial Group from $135.00 to $140.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 26th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $150.75.

Read Our Latest Stock Analysis on AFG

American Financial Group Stock Performance NYSE:AFG opened at $142.25 on Tuesday. American Financial Group, Inc. has a twelve month low of $122.11 and a twelve month high of $150.02. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $11.82 billion, a P/E ratio of 13.52 and a beta of 0.62. The company has a fifty day moving average of $136.15 and a 200-day moving average of $132.36.

American Financial Group (NYSE:AFG – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The insurance provider reported $2.47 earnings per share for the quarter, missing the consensus estimate of $2.54 by ($0.07). The company had revenue of $1.85 billion for the quarter, compared to analyst estimates of $1.70 billion. American Financial Group had a net margin of 10.76% and a return on equity of 19.50%. American Financial Group’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.81 EPS. As a group, sell-side analysts anticipate that American Financial Group, Inc. will post 11.37 EPS for the current year.

American Financial Group Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Friday, July 24th. Shareholders of record on Wednesday, July 15th will be issued a $0.88 dividend. The ex-dividend date is Wednesday, July 15th. This represents a $3.52 annualized dividend and a yield of 2.5%. American Financial Group’s dividend payout ratio is presently 33.46%.

Insider Buying and Selling In other American Financial Group news, insider David Lawrence Thompson, Jr. sold 11,370 shares of the company’s stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $135.05, for a total transaction of $1,535,518.50. Following the transaction, the insider owned 584,098 shares in the company, valued at approximately $78,882,434.90. This represents a 1.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Michelle A. Gillis sold 2,247 shares of American Financial Group stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $139.00, for a total transaction of $312,333.00. Following the transaction, the senior vice president owned 13,135 shares of the company’s stock, valued at $1,825,765. This represents a 14.61% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 16.90% of the stock is owned by corporate insiders.

About American Financial Group (Free Report)

American Financial Group, Inc (NYSE: AFG) is a diversified holding company primarily engaged in property and casualty insurance and reinsurance. Through its flagship subsidiary, Great American Insurance Company, the firm underwrites a broad range of specialty insurance products for commercial and industrial clients, including inland marine, excess and surplus lines, executive liability, and environmental liability coverage. In addition, American Financial Group offers supplemental accident and health insurance and assumes reinsurance risks from other insurers, helping to diversify its underwriting portfolio.

The company traces its roots to 1946, when it was founded by Carl Lindner, Sr.

Featured Stories Five stocks we like better than American Financial Group The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding AFG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Financial Group, Inc. (NYSE:AFG – Free Report).

Receive News & Ratings for American Financial Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Financial Group and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 21st, 2026

Andra AP fonden raised its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 320.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 121,405 shares of the medical research company’s stock after purchasing an additional 92,505 shares during the quarter. Andra AP fonden owned 0.07% of IQVIA worth $20,704,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. J. Safra Sarasin Holding AG lifted its holdings in IQVIA by 174.3% during the 4th quarter. J. Safra Sarasin Holding AG now owns 12,827 shares of the medical research company’s stock worth $2,891,000 after buying an additional 8,151 shares during the last quarter. CWM LLC increased its holdings in shares of IQVIA by 23.9% in the 4th quarter. CWM LLC now owns 55,830 shares of the medical research company’s stock valued at $12,585,000 after acquiring an additional 10,762 shares during the last quarter. Franklin Street Advisors Inc. NC acquired a new stake in shares of IQVIA during the 4th quarter valued at approximately $15,724,000. Calamos Advisors LLC lifted its stake in IQVIA by 268.1% during the fourth quarter. Calamos Advisors LLC now owns 188,707 shares of the medical research company’s stock worth $42,536,000 after purchasing an additional 137,441 shares during the last quarter. Finally, HF Advisory Group LLC increased its stake in IQVIA by 1,791.6% during the fourth quarter. HF Advisory Group LLC now owns 154,618 shares of the medical research company’s stock valued at $34,852,000 after purchasing an additional 146,444 shares during the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

Analyst Ratings Changes A number of research analysts have recently issued reports on IQV shares. Morgan Stanley restated an “equal weight” rating and issued a $200.00 price target (down from $225.00) on shares of IQVIA in a research report on Wednesday, June 17th. HSBC reaffirmed a “buy” rating and set a $240.00 price objective on shares of IQVIA in a research report on Monday, July 6th. Deutsche Bank Aktiengesellschaft set a $240.00 target price on shares of IQVIA in a report on Thursday, July 9th. Wall Street Zen lowered IQVIA from a “buy” rating to a “hold” rating in a report on Saturday, June 27th. Finally, Robert W. Baird increased their price target on IQVIA from $230.00 to $249.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 1st. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $225.71.

Get Our Latest Research Report on IQVIA

IQVIA Trading Down 0.9% IQVIA stock opened at $204.33 on Tuesday. IQVIA Holdings Inc. has a 52-week low of $154.50 and a 52-week high of $247.04. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 2.20. The firm has a market capitalization of $34.10 billion, a price-to-earnings ratio of 25.32, a PEG ratio of 1.85 and a beta of 1.20. The firm has a 50-day moving average price of $185.66 and a two-hundred day moving average price of $187.72.

IQVIA (NYSE:IQV – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The medical research company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.83 by $0.07. The company had revenue of $4.15 billion for the quarter, compared to analyst estimates of $4.10 billion. IQVIA had a net margin of 8.33% and a return on equity of 30.50%. IQVIA’s revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the business earned $2.70 earnings per share. IQVIA has set its FY 2026 guidance at 12.650-12.950 EPS. Sell-side analysts expect that IQVIA Holdings Inc. will post 11.57 earnings per share for the current year.

IQVIA declared that its board has initiated a stock buyback program on Thursday, May 7th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical research company to buy up to 6.8% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

IQVIA Company Profile (Free Report)

IQVIA (NYSE: IQV) is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. The company combines clinical research capabilities with large-scale health data and analytics to support drug development, regulatory reporting, commercial strategy and real‑world evidence generation. IQVIA traces its current form to the combination of Quintiles and IMS Health announced in 2016 and subsequently rebranded as IQVIA, bringing together long-established clinical research operations and extensive healthcare information assets.

IQVIA’s principal activities include outsourced clinical development services (acting as a contract research organization for phases I–IV), real‑world evidence and observational research, regulatory and safety services, and a suite of technology platforms that enable data integration, analytics and operational management.

Read More Five stocks we like better than IQVIA The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Free Report).

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEiShares MSCI EAFE Value ETF $EFV Stock Holdings Trimmed by Assetmark Inc.

NEXT HEADLINE »Assetmark Inc. Increases Stock Holdings in Stryker Corporation $SYK

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions. “As healthcare sys.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PicS To Contact Him Directly To Discuss Their Options

If you purchased or acquired PicS Class A Common stock in and/or traceable to PicS' January 30, 2026 initial public offering ("IPO") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - July 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PicS N.V. ("PicS" or the "Company") (NASDAQ: PICS) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) PicS N.V. had conducted an evaluation of its credit evaluation procedures in December 2025 and determined that such procedures were deficient and in need of enhancement; (2) as a result of the new procedures PicS N.V. had implemented in December 2025, PicS N.V. had reclassified approximately R$590 million of exposures previously classified as Stage 2 to Stage 3, leading to an incremental ECL charge of R$88 million in the three months ended December 31, 2025; (3) PicS N.V. had experienced a heightened, but unreported, Stage 3 formation rate of more than 7% in the fourth quarter of 2025 that deviated substantially from the historical results and trends provided in the offering documents; (4) the IPO's offering documents had materially overstated the quality and ability of PicS N.V.'s credit models and user data to inform PicS N.V.'s underwriting practices and to allow PicS N.V. to timely and effectively monitor, assess, and identify adverse credit events, credit risks, and credit deterioration across its portfolio; and (5) PicS N.V. suffered from degradations in customer credit quality and heightened risks of default and loan impairment as a result of its entrance into materially riskier business lines leading up to the IPO, resulting in undisclosed adverse financial and operational trends such as heightened incidents of default, which predated the IPO and were internally projected by PicS N.V. to continue to worsen following the IPO, materially impairing PicS N.V.'s business, operations, and financial results.

On or around January 29, 2026, PicPay conducted its initial public offering ("IPO"), selling 22.86 million Class A common shares priced at $19.00 per share.

Then, on March 18, 2026, PicPay released its fourth quarter 2025 financial results and revealed that, as part of the Company's "annual review of expected credit loss parameters," it had made several "enhancements" to its Expected Credit Loss ("ECL") calculations, and "implemented a stricter policy to accelerate the classification of renegotiated non-performing exposures from Stage 2 to Stage 3." Consequently, "R$590 million of Stage 2 portfolio balances were reclassified to Stage 3, resulting in an ECL increase of R$88 [$17.56 million USD]." Stage 3 is the Company's highest risk category for its credit portfolio.

On this news, PicPay's stock price fell $3.56 per share, or 22.5%, to close at $12.27 per share on March 19, 2026.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding PicS' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the PicS N.V. class action, go to www.faruqilaw.com/PICS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the PicS N.V. Securities Class Action Lawsuit:

What is the PicS N.V. securities fraud lawsuit about?

The PicS N.V. securities fraud lawsuit is a federal securities class action alleging that PicS N.V. (NASDAQ: PICS) and its executives made false and misleading statements to investors in connection with the Company's January 30, 2026 IPO by concealing that the Company had already identified deficiencies in its credit evaluation procedures in December 2025, had reclassified approximately R$590 million of exposures from Stage 2 to Stage 3 (its highest credit risk category) resulting in an incremental expected credit loss charge of R$88 million, and was experiencing a Stage 3 formation rate exceeding 7% in Q4 2025 - a significant deviation from the historical trends presented in the IPO's offering documents. As the truth emerged on March 18, 2026, when PicS disclosed these credit portfolio deteriorations as part of its Q4 2025 financial results, PICS shares fell $3.56 per share, or 22.5%, to close at $12.27 - well below the $19.00 IPO price - causing significant losses for investors.

Who may be eligible to participate in the PicS N.V. class action lawsuit?

Investors who purchased PicS N.V. (PICS) Class A common stock in and/or traceable to the Company's January 30, 2026 initial public offering and suffered financial losses may be eligible to participate in the PicS securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former PicS employees, and others with relevant information about the Company's conduct are also encouraged to come forward.

What is a lead plaintiff, and how can I seek appointment in the PicS N.V. lawsuit?

A lead plaintiff in the PicS N.V. class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any PicS investor who purchased PICS Class A common stock in or traceable to the IPO may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is August 4, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.

What should investors do if they purchased PicS N.V. stock in the IPO?

Investors who purchased PicS N.V. (PICS) Class A common stock in and/or traceable to the January 30, 2026 IPO and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the PicS N.V. securities class action is August 4, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/PICS for more information.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305849

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Posted by Defense World Staff on Jul 21st, 2026

California Public Employees Retirement System increased its position in shares of United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 5.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 88,289 shares of the biotechnology company’s stock after acquiring an additional 4,933 shares during the quarter. California Public Employees Retirement System owned about 0.21% of United Therapeutics worth $52,354,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UTHR. Avoro Capital Advisors LLC raised its position in shares of United Therapeutics by 17.3% in the 4th quarter. Avoro Capital Advisors LLC now owns 2,606,060 shares of the biotechnology company’s stock valued at $1,269,803,000 after purchasing an additional 383,838 shares during the last quarter. Wellington Management Group LLP grew its position in United Therapeutics by 74.5% during the 4th quarter. Wellington Management Group LLP now owns 2,441,492 shares of the biotechnology company’s stock worth $1,189,617,000 after purchasing an additional 1,042,711 shares during the last quarter. AQR Capital Management LLC grew its position in United Therapeutics by 29.9% during the 4th quarter. AQR Capital Management LLC now owns 1,281,699 shares of the biotechnology company’s stock worth $624,508,000 after purchasing an additional 295,221 shares during the last quarter. Janus Henderson Group PLC increased its stake in United Therapeutics by 75.1% during the 4th quarter. Janus Henderson Group PLC now owns 796,101 shares of the biotechnology company’s stock valued at $387,801,000 after purchasing an additional 341,383 shares in the last quarter. Finally, Norges Bank acquired a new position in United Therapeutics during the 4th quarter valued at approximately $293,418,000. Hedge funds and other institutional investors own 94.08% of the company’s stock.

Analysts Set New Price Targets UTHR has been the subject of a number of research analyst reports. HC Wainwright raised their target price on United Therapeutics from $600.00 to $660.00 and gave the stock a “buy” rating in a research note on Tuesday, March 31st. Bank of America dropped their price target on United Therapeutics from $620.00 to $613.00 and set a “neutral” rating on the stock in a research note on Friday, July 10th. Raymond James Financial initiated coverage on United Therapeutics in a report on Friday, April 10th. They issued an “outperform” rating and a $700.00 price objective on the stock. Wells Fargo & Company upgraded United Therapeutics from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $575.00 to $735.00 in a research note on Thursday, May 7th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of United Therapeutics in a report on Thursday, June 11th. Ten investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, United Therapeutics presently has a consensus rating of “Moderate Buy” and a consensus target price of $644.82.

Read Our Latest Report on UTHR

Insiders Place Their Bets In related news, CFO James Edgemond sold 10,000 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $576.93, for a total transaction of $5,769,300.00. Following the completion of the sale, the chief financial officer owned 18,876 shares of the company’s stock, valued at approximately $10,890,130.68. This represents a 34.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold 545,243 shares of company stock worth $305,155,272 in the last quarter. Insiders own 8.60% of the company’s stock.

United Therapeutics Price Performance United Therapeutics stock opened at $529.34 on Tuesday. The stock has a market capitalization of $22.47 billion, a PE ratio of 19.54, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. The business has a 50 day simple moving average of $551.57 and a 200-day simple moving average of $530.56. United Therapeutics Corporation has a 12 month low of $272.12 and a 12 month high of $609.35.

United Therapeutics (NASDAQ:UTHR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $5.82 earnings per share for the quarter, missing analysts’ consensus estimates of $7.00 by ($1.18). The company had revenue of $781.50 million during the quarter, compared to analysts’ expectations of $797.40 million. United Therapeutics had a net margin of 40.62% and a return on equity of 19.24%. The company’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.63 earnings per share. On average, equities research analysts anticipate that United Therapeutics Corporation will post 26.63 EPS for the current fiscal year.

About United Therapeutics (Free Report)

United Therapeutics Corporation (NASDAQ: UTHR) is a biotechnology company dedicated to the development and commercialization of unique products to address life-threatening illnesses. The company’s primary focus has been on pulmonary arterial hypertension (PAH), where it has launched several therapies designed to improve functional capacity and quality of life for patients. Its marketed products include continuous infusion treprostinil (Remodulin), inhaled treprostinil (Tyvaso), oral treprostinil (Orenitram) and tadalafil (Adcirca), each tailored to different modes of administration and patient needs.

Featured Stories Five stocks we like better than United Therapeutics The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding UTHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for United Therapeutics Corporation (NASDAQ:UTHR – Free Report).

Receive News & Ratings for United Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Increases Position in NRG Energy, Inc. $NRG

NEXT HEADLINE »California Public Employees Retirement System Cuts Holdings in CMS Energy Corporation $CMS

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox.

Newly enacted housing legislation that bans institutional investors from purchasing single-family rental homes has those same investors putting up more for sale signs.

The number of homes owned by institutional investors listed for sale is, as of this month, more than double what it was at the start of February, according to an analysis provided exclusively to Property Play by Parcl Labs, a real estate data provider.

Listings have gone from 4,166 on Feb. 1, when Parcl launched its full research, to now 9,447 homes representing $3.1 billion in total asking price.

"The rate of for-sale change is something to keep an eye on," said Jason Lewris, co-founder at Parcl Labs. "These numbers won't materialize into actual dispositions for months given how long the sales cycle can be, but it's the fastest read into institutional behavior."

The legislation defined institutional investors as those owning 350 or more homes. That was a surprise to the industry, which traditionally set that bar at 1,000 homes. It does not force them to sell the homes they currently own, but they are barred from buying any more homes unless they fall under certain exceptions, including build-to-rent.

The charge by lawmakers was that these investors, most of whom were able to buy the homes with all cash, were inflating prices and sidelining regular owner-occupant buyers. The call for a ban was bipartisan.

Large scale investors first entered the market during the financial crisis in 2008, when foreclosures were rampant and bulk auctions were popping up in the hardest hit markets, like Atlanta, Las Vegas, and Phoenix. Private equity firms purchased thousands of homes in a short period, converting them to rentals and creating a new single-family rental asset class.

The cohort of investors with 350 or more homes that therefore fall under the new legislation now own roughly 589,000 homes, or 3.9% of the 14 million single family rental homes in the U.S., according to Parcl. They account for roughly 40% of the net selling year-to-date.

The largest landlords — Progress Residential, Invitation Homes, AMH, Tricon, FirstKey, Amherst and VineBrook — are all net sellers year-to-date, with 3,180 more homes sold than bought since Jan. 1. To put that in perspective, they still own about 400,000 homes, so it's not exactly a liquidation sale, with one exception. VineBrook currently has nearly 10% of its portfolio on the market, roughly 1,900 homes with a total asking price of $285 million.

Invitation homes and AMH, the two publicly traded, single-family rental REITs, have 549 and 536 homes for sale, respectively. The largest landlord, Progress Residential, has the least of the larger players, just 143 for sale.

"There is broad recognition now both by the White House and lawmakers, in an overwhelming majority, that private capital has a very big role to play for a component of the American population that wants to rent a home," said Stephen Scherr, co-president of Pretium, in an interview last week on CNBC's "Squawk on the Street." Pretium is the parent company of Progress Residential. 

Progress is now focusing on the areas that the new legislation allows and which the industry fought hard for during the legislative process.

"We can buy build-to-rent, which is a predominant component of new housing. We can buy under various other exceptions including rent-to-renovate, where we improve the housing stock or we buy under a homeownership boost, where we give people an opportunity to transition where they want from renters to owners," Sherr said.

The build-to-rent play has been gaining significant steam over the past few years as demand for single-family rental housing grows.

AMH started early, in 2017, building its own homes. It has so far developed more than 14,000 homes for rent in 180 communities, according to the company. Invitation Homes purchased an Atlanta-based homebuilder, ResiBuilt, at the beginning of this year. 

"The financing case has materially changed with the forced disposition mandate removed. Lenders can underwrite [build-to-rent] again, and we're starting to see this happen," Chris Nebenzahl, vice president of rental research at John Burns Research and Consulting, wrote in a report. 

The investors who are selling are offering discounts on the properties. Nationally, 38.7% of all listings for sale today have had price cuts compared with 54% within the institutional, single-family rental cohort, according to Parcl Labs. Since early May, markdowns have deepened from about 3.1% to 4% of asking value. Meanwhile, 54% of the investor listings for those in the more than 350 homes category carry a price cut.

"From what we can tell, given where U.S. home prices are, some of this is attributed to shifts in strategy — collect high dollar values off of top U.S. home values by culling underperforming assets and redirect that capital towards growth areas, i.e. build-to-rent, for example," Lewris said in a statement, adding that the next six to eight weeks will be telling.

Get Property Play directly to your inboxCNBC's Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox.

Subscribe here to get access today.

Posted by Defense World Staff on Jul 21st, 2026

Bessemer Group Inc. grew its holdings in shares of First Hawaiian, Inc. (NASDAQ:FHB – Free Report) by 41.0% in the first quarter, according to its most recent filing with the SEC. The firm owned 230,841 shares of the bank’s stock after acquiring an additional 67,083 shares during the quarter. Bessemer Group Inc. owned about 0.19% of First Hawaiian worth $5,688,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of FHB. Oak Thistle LLC bought a new stake in First Hawaiian in the fourth quarter worth about $1,243,000. SG Americas Securities LLC boosted its position in shares of First Hawaiian by 409.2% during the 4th quarter. SG Americas Securities LLC now owns 89,506 shares of the bank’s stock valued at $2,265,000 after purchasing an additional 71,927 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of First Hawaiian by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 14,457,575 shares of the bank’s stock worth $365,777,000 after purchasing an additional 358,632 shares during the last quarter. Ruffer LLP acquired a new position in shares of First Hawaiian in the 4th quarter worth approximately $3,028,000. Finally, UBS Group AG raised its holdings in shares of First Hawaiian by 176.0% in the 4th quarter. UBS Group AG now owns 1,128,002 shares of the bank’s stock worth $28,538,000 after purchasing an additional 719,312 shares in the last quarter. Institutional investors own 97.63% of the company’s stock.

Analysts Set New Price Targets Several analysts recently commented on the stock. Wall Street Zen lowered shares of First Hawaiian from a “hold” rating to a “sell” rating in a research note on Saturday, May 9th. Wells Fargo & Company lifted their price target on shares of First Hawaiian from $26.00 to $28.00 and gave the stock an “underweight” rating in a research report on Monday, July 6th. TD Cowen upped their price target on First Hawaiian from $28.00 to $29.00 and gave the company a “hold” rating in a report on Tuesday, April 28th. Benchmark reiterated a “hold” rating on shares of First Hawaiian in a research report on Tuesday, July 14th. Finally, The Goldman Sachs Group raised their price objective on First Hawaiian from $27.00 to $30.00 and gave the stock a “sell” rating in a research note on Tuesday, July 7th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $29.25.

Get Our Latest Research Report on FHB

First Hawaiian Price Performance Shares of FHB opened at $28.86 on Tuesday. The company has a 50-day moving average of $28.19 and a two-hundred day moving average of $26.77. The stock has a market cap of $3.51 billion, a price-to-earnings ratio of 12.66, a PEG ratio of 1.60 and a beta of 0.72. First Hawaiian, Inc. has a one year low of $22.65 and a one year high of $30.58.

First Hawaiian (NASDAQ:FHB – Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The bank reported $0.55 EPS for the quarter, beating the consensus estimate of $0.53 by $0.02. First Hawaiian had a net margin of 24.44% and a return on equity of 10.39%. The business had revenue of $220.35 million during the quarter, compared to the consensus estimate of $223.59 million. During the same quarter in the prior year, the firm earned $0.47 EPS. Analysts anticipate that First Hawaiian, Inc. will post 2.38 earnings per share for the current year.

First Hawaiian Announces Dividend The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Monday, May 18th were paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 3.6%. The ex-dividend date of this dividend was Monday, May 18th. First Hawaiian’s payout ratio is 45.61%.

About First Hawaiian (Free Report)

First Hawaiian, Inc is the oldest and largest bank in Hawaii, operating as the bank holding company for First Hawaiian Bank. Established in 1858, the company offers a full suite of financial services to individual, business and institutional clients. Its product portfolio includes consumer and commercial lending, deposit accounts, treasury and cash management, foreign exchange and trade finance, as well as wealth management and trust services.

First Hawaiian serves customers through an extensive network of branches, ATMs and digital channels across the Hawaiian Islands, Guam, Saipan and American Samoa.

Read More Five stocks we like better than First Hawaiian The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding FHB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for First Hawaiian, Inc. (NASDAQ:FHB – Free Report).

Receive News & Ratings for First Hawaiian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Hawaiian and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBessemer Group Inc. Grows Stake in Teleflex Incorporated $TFX

NEXT HEADLINE »Gerald Baker Financial Group LLC Takes $24.02 Million Position in ExxonMobil Corporation $XOM

Atlantic Union (AUB - Free Report) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.95 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +2.17%. A quarter ago, it was expected that this holding company for Atlantic Union Bank would post earnings of $0.88 per share when it actually produced earnings of $0.89, delivering a surprise of +1.14%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Atlantic Union, which belongs to the Zacks Banks - Northeast industry, posted revenues of $419.93 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 6.32%. This compares to year-ago revenues of $407.26 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Atlantic Union shares have added about 19.1% since the beginning of the year versus the S&P 500's gain of 8.7%.

What's Next for Atlantic Union?While Atlantic Union has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Atlantic Union was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.96 on $394.02 million in revenues for the coming quarter and $3.74 on $1.56 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Northeast is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Carter Bankshares, Inc. (CARE - Free Report) , is yet to report results for the quarter ended June 2026.

This company is expected to post quarterly earnings of $0.41 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Carter Bankshares, Inc.'s revenues are expected to be $66.73 million, up 78.2% from the year-ago quarter.

Posted by Defense World Staff on Jul 21st, 2026

Bank of New York Mellon Corp decreased its stake in shares of Crown Holdings, Inc. (NYSE:CCK – Free Report) by 12.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,159,975 shares of the industrial products company’s stock after selling 165,311 shares during the quarter. Bank of New York Mellon Corp owned approximately 1.03% of Crown worth $116,288,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Illinois Municipal Retirement Fund increased its stake in shares of Crown by 232.0% during the first quarter. Illinois Municipal Retirement Fund now owns 19,400 shares of the industrial products company’s stock worth $1,945,000 after buying an additional 13,556 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in Crown by 27.4% in the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 7,641 shares of the industrial products company’s stock worth $766,000 after acquiring an additional 1,643 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Crown by 2.0% in the first quarter. Principal Financial Group Inc. now owns 250,252 shares of the industrial products company’s stock worth $25,088,000 after acquiring an additional 5,025 shares during the last quarter. Chicago Partners Investment Group LLC grew its holdings in Crown by 7.5% during the 1st quarter. Chicago Partners Investment Group LLC now owns 12,352 shares of the industrial products company’s stock worth $1,258,000 after acquiring an additional 866 shares in the last quarter. Finally, Arbejdsmarkedets Tillaegspension increased its position in shares of Crown by 1.0% in the 1st quarter. Arbejdsmarkedets Tillaegspension now owns 249,499 shares of the industrial products company’s stock valued at $25,012,000 after purchasing an additional 2,589 shares during the last quarter. Hedge funds and other institutional investors own 90.93% of the company’s stock.

Analyst Upgrades and Downgrades Several equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of Crown from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. JPMorgan Chase & Co. upgraded Crown from a “neutral” rating to an “overweight” rating and set a $107.00 price target on the stock in a research note on Monday, May 18th. BMO Capital Markets started coverage on Crown in a report on Thursday. They set an “outperform” rating and a $130.00 price target for the company. Citigroup upped their price objective on Crown from $127.00 to $129.00 and gave the stock a “buy” rating in a research report on Wednesday, April 29th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Crown in a report on Wednesday, April 1st. They issued a “buy” rating and a $124.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Crown has a consensus rating of “Moderate Buy” and an average target price of $124.07.

Get Our Latest Stock Report on Crown

Insider Transactions at Crown In other Crown news, CEO Timothy J. Donahue sold 15,000 shares of Crown stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $105.00, for a total value of $1,575,000.00. Following the transaction, the chief executive officer directly owned 436,070 shares in the company, valued at approximately $45,787,350. The trade was a 3.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.90% of the company’s stock.

Key Crown News Here are the key news stories impacting Crown this week:

Positive Sentiment: Second-quarter earnings beat Wall Street estimates, with Crown reporting $2.49 EPS versus $2.15 expected, and revenue of $3.67 billion versus $3.37 billion expected. Crown Holdings Q2 Earnings and Revenues Top Estimates Positive Sentiment: Management lifted FY 2026 EPS guidance to $8.30-$8.50, above the $8.10 consensus, signaling confidence in full-year profitability. Positive Sentiment: Operational momentum improved as global beverage can volumes rose 5%, supporting higher sales and suggesting steady demand in Crown’s core packaging business. Crown Holdings Posts Higher Sales As Global Beverage Can Volumes Rise Neutral Sentiment: The company’s Q3 EPS guidance of $2.20-$2.30 was slightly below the $2.25 consensus midpoint, which may limit upside as investors assess whether the strong second quarter can carry forward. Neutral Sentiment: Technical commentary noted a recent golden cross, which can be viewed as a constructive long-term chart signal, though it was not a direct fundamental driver. Should You Buy Crown Holdings After Golden Cross? Crown Trading Down 2.1% CCK opened at $114.73 on Tuesday. The company has a quick ratio of 0.70, a current ratio of 1.12 and a debt-to-equity ratio of 1.67. Crown Holdings, Inc. has a 52 week low of $89.21 and a 52 week high of $118.50. The business’s 50 day moving average is $103.18 and its two-hundred day moving average is $104.80. The firm has a market cap of $12.82 billion, a price-to-earnings ratio of 18.27, a price-to-earnings-growth ratio of 1.96 and a beta of 0.60.

Crown (NYSE:CCK – Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The industrial products company reported $2.49 earnings per share for the quarter, beating the consensus estimate of $2.15 by $0.34. The business had revenue of $3.67 billion during the quarter, compared to the consensus estimate of $3.37 billion. Crown had a return on equity of 26.62% and a net margin of 5.65%.During the same period in the prior year, the company earned $2.15 earnings per share. Crown has set its Q3 2026 guidance at 2.200-2.30 EPS and its FY 2026 guidance at 8.300-8.50 EPS. On average, research analysts predict that Crown Holdings, Inc. will post 8.06 EPS for the current year.

Crown Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were given a dividend of $0.35 per share. This represents a $1.40 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend was Thursday, May 14th. Crown’s dividend payout ratio (DPR) is presently 22.29%.

Crown Profile (Free Report)

Crown Holdings, Inc is a leading global supplier of rigid packaging products for consumer goods markets. The company designs, manufactures and sells metal packaging for beverage, food, household, personal care and specialty products. Its portfolio includes aluminum and steel beverage cans, steel food cans, aluminum aerosols, metal closures and ends, offering customers end-to-end solutions from design and prototyping to large-scale production.

Founded in 1919 as the Crown Cork & Seal Company, Crown has grown through strategic acquisitions and investments in advanced manufacturing technologies.

See Also Five stocks we like better than Crown The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding CCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crown Holdings, Inc. (NYSE:CCK – Free Report).

Receive News & Ratings for Crown Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crown and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBaader Bank Aktiengesellschaft Purchases New Shares in Klarna Group plc $KLAR

NEXT HEADLINE »Baader Bank Aktiengesellschaft Decreases Position in Tesla, Inc. $TSLA

D.A. Davidson & CO. grew its holdings in shares of Fifth Third Bancorp (NASDAQ:FITB – Free Report) by 69.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 50,783 shares of the financial services provider’s stock after purchasing an additional 20,862 shares during the period. D.A. Davidson & CO.’s holdings in Fifth Third Bancorp were worth $2,359,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of FITB. Vanguard Group Inc. grew its position in Fifth Third Bancorp by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 83,948,876 shares of the financial services provider’s stock valued at $3,929,647,000 after buying an additional 637,207 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Fifth Third Bancorp by 41.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 35,548,204 shares of the financial services provider’s stock worth $1,664,013,000 after buying an additional 10,444,799 shares in the last quarter. Capital World Investors raised its position in shares of Fifth Third Bancorp by 5.6% during the 4th quarter. Capital World Investors now owns 32,549,669 shares of the financial services provider’s stock worth $1,523,650,000 after buying an additional 1,719,361 shares in the last quarter. State Street Corp lifted its stake in shares of Fifth Third Bancorp by 0.3% in the 4th quarter. State Street Corp now owns 31,437,600 shares of the financial services provider’s stock worth $1,484,021,000 after acquiring an additional 101,245 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Fifth Third Bancorp by 2.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 23,939,023 shares of the financial services provider’s stock worth $1,120,586,000 after acquiring an additional 530,489 shares during the period. 83.79% of the stock is currently owned by institutional investors.

Fifth Third Bancorp Stock Performance Shares of FITB opened at $57.47 on Tuesday. The firm’s 50 day moving average is $53.19 and its 200-day moving average is $50.70. The stock has a market capitalization of $52.09 billion, a P/E ratio of 19.29, a P/E/G ratio of 1.09 and a beta of 0.90. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.83 and a quick ratio of 0.83. Fifth Third Bancorp has a 12-month low of $40.04 and a 12-month high of $59.50.

Fifth Third Bancorp (NASDAQ:FITB – Get Free Report) last released its earnings results on Friday, July 17th. The financial services provider reported $0.83 EPS for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.01). Fifth Third Bancorp had a return on equity of 12.39% and a net margin of 15.89%.The business had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the firm earned $0.88 earnings per share. Equities research analysts anticipate that Fifth Third Bancorp will post 4.1 EPS for the current fiscal year.

Fifth Third Bancorp Announces Dividend The business also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th were issued a $0.40 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.60 annualized dividend and a dividend yield of 2.8%. Fifth Third Bancorp’s dividend payout ratio is currently 54.61%.

Insider Activity at Fifth Third Bancorp In other news, EVP Peter L. Sefzik sold 20,000 shares of the stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $50.46, for a total transaction of $1,009,200.00. Following the completion of the sale, the executive vice president owned 189,382 shares in the company, valued at approximately $9,556,215.72. This represents a 9.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.51% of the company’s stock.

Analysts Set New Price Targets A number of research analysts recently commented on FITB shares. Royal Bank Of Canada raised their price objective on shares of Fifth Third Bancorp from $57.00 to $62.00 and gave the company an “outperform” rating in a research note on Monday. JPMorgan Chase & Co. upped their target price on Fifth Third Bancorp from $54.50 to $61.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Wolfe Research cut their target price on Fifth Third Bancorp from $57.00 to $55.00 and set an “outperform” rating for the company in a research report on Wednesday, April 1st. Zacks Research lowered Fifth Third Bancorp from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Finally, Keefe, Bruyette & Woods lifted their price target on Fifth Third Bancorp from $58.00 to $60.00 and gave the company a “market perform” rating in a research report on Monday. Seventeen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Fifth Third Bancorp presently has a consensus rating of “Moderate Buy” and an average price target of $60.20.

Check Out Our Latest Stock Analysis on FITB

Key Fifth Third Bancorp News Here are the key news stories impacting Fifth Third Bancorp this week:

Positive Sentiment: Bank of America raised its price target to $65 and kept a buy rating, signaling meaningful upside from current levels. Article Title Positive Sentiment: DA Davidson also lifted its target to $65 and reiterated a buy rating after Fifth Third’s strong quarter. Article Title Positive Sentiment: RBC raised its target to $62 with an outperform rating, adding to the bullish analyst sentiment around FITB. Article Title Positive Sentiment: Keefe, Bruyette & Woods increased its target to $60, signaling still-positive expectations even with a more neutral stance. Article Title Positive Sentiment: Fifth Third reported Q2 EPS of $1.02, ahead of the $0.95 consensus, with revenue also beating estimates, reinforcing the bank’s fundamental strength. Article Title Positive Sentiment: Fifth Third won Euromoney’s Best Bank Award in the United States, which may support its reputation and brand strength. Article Title Neutral Sentiment: Industry commentary on banks using fintech and embedded finance for deposits suggests a broader opportunity set, but it is not a direct company-specific catalyst. Article Title Neutral Sentiment: One article framed Comerica as a growth catalyst for Fifth Third, but the impact appears more strategic than immediately measurable. Article Title Neutral Sentiment: Unusually high options trading was noted, which can signal heightened investor attention but does not by itself explain the move. Article Title Positive Sentiment: A Zacks article highlighted Fifth Third as a strong dividend stock, which may appeal to income-focused investors. Article Title Fifth Third Bancorp Profile (Free Report)

Fifth Third Bancorp is a Cincinnati, Ohio–based bank holding company whose primary banking subsidiary operates as Fifth Third Bank. The company provides a broad range of financial services to individual consumers, small businesses, middle-market companies and large corporations. Its business mix includes retail and commercial banking, lending, payment and card services, treasury and cash management, and wealth management and investment advisory services delivered through a combination of branch locations, commercial offices and digital platforms.

On the consumer side, Fifth Third offers deposit accounts, consumer loans, mortgages, auto financing and credit card products, along with digital banking and mobile services.

Featured Articles Five stocks we like better than Fifth Third Bancorp The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Fifth Third Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fifth Third Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.

Alaska Air Group, Inc. (NYSE:ALK) will release its second quarter earnings report after the closing bell on Tuesday, July 21.

Analysts expect the Seattle, Washington-based company to report a quarterly loss of 99 cents per share, versus a profit of $1.78 per share in the year-ago period. The consensus estimate for Alaska Air’s quarterly revenue is $4.09 billion. It reported $3.7 billion last year, according to Benzinga Pro.

On April 20, Alaska Air reported worse-than-expected first-quarter fiscal year 2026 results and suspended guidance.

Shares of Alaska Air rose 1.2% to close at $46.04 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

Considering buying ALK stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted by Defense World Staff on Jul 21st, 2026

Baader Bank Aktiengesellschaft acquired a new stake in Comfort Systems USA, Inc. (NYSE:FIX – Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 1,407 shares of the construction company’s stock, valued at approximately $1,914,000.

A number of other institutional investors have also recently modified their holdings of the stock. Andra AP fonden increased its stake in Comfort Systems USA by 79.7% in the first quarter. Andra AP fonden now owns 14,013 shares of the construction company’s stock valued at $19,324,000 after acquiring an additional 6,213 shares during the last quarter. Summit Global Investments acquired a new stake in shares of Comfort Systems USA in the 1st quarter valued at approximately $411,000. Convergence Investment Partners LLC bought a new stake in shares of Comfort Systems USA during the 1st quarter valued at approximately $2,226,000. Commerzbank Aktiengesellschaft FI acquired a new position in shares of Comfort Systems USA during the first quarter worth $1,524,000. Finally, Hollencrest Capital Management bought a new stake in Comfort Systems USA during the 1st quarter worth $48,000. 96.51% of the stock is currently owned by institutional investors.

Insider Activity In other news, insider Brian E. Lane sold 11,113 shares of the business’s stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $1,969.84, for a total transaction of $21,890,831.92. Following the completion of the transaction, the insider owned 161,089 shares of the company’s stock, valued at approximately $317,319,555.76. The trade was a 6.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO William George III sold 1,000 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $2,020.96, for a total value of $2,020,960.00. Following the transaction, the chief financial officer directly owned 32,804 shares of the company’s stock, valued at $66,295,571.84. The trade was a 2.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 30,778 shares of company stock worth $59,746,124. Company insiders own 1.24% of the company’s stock.

Comfort Systems USA Price Performance NYSE FIX opened at $1,712.83 on Tuesday. Comfort Systems USA, Inc. has a 52 week low of $513.99 and a 52 week high of $2,073.99. The firm’s 50-day simple moving average is $1,855.02 and its two-hundred day simple moving average is $1,549.75. The company has a quick ratio of 1.21, a current ratio of 1.24 and a debt-to-equity ratio of 0.01. The company has a market cap of $60.29 billion, a PE ratio of 49.42 and a beta of 1.66.

Comfort Systems USA (NYSE:FIX – Get Free Report) last released its quarterly earnings data on Thursday, April 23rd. The construction company reported $10.51 EPS for the quarter, beating analysts’ consensus estimates of $6.81 by $3.70. The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.39 billion. Comfort Systems USA had a net margin of 12.07% and a return on equity of 51.69%. Comfort Systems USA’s revenue was up 56.5% compared to the same quarter last year. During the same period last year, the business earned $4.75 earnings per share. Research analysts predict that Comfort Systems USA, Inc. will post 43.39 earnings per share for the current year.

Comfort Systems USA Increases Dividend The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Shareholders of record on Friday, May 15th were issued a $0.80 dividend. This represents a $3.20 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, May 15th. This is an increase from Comfort Systems USA’s previous quarterly dividend of $0.70. Comfort Systems USA’s payout ratio is 9.23%.

Analysts Set New Price Targets Several equities analysts have commented on the company. Zacks Research downgraded Comfort Systems USA from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 26th. Oppenheimer assumed coverage on shares of Comfort Systems USA in a report on Thursday, May 28th. They issued an “outperform” rating and a $2,200.00 target price on the stock. Stifel Nicolaus raised their price target on shares of Comfort Systems USA from $1,611.00 to $1,819.00 and gave the stock a “buy” rating in a report on Thursday, April 16th. Glj Research initiated coverage on shares of Comfort Systems USA in a research report on Monday, April 20th. They set a “buy” rating and a $2,001.00 target price for the company. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Comfort Systems USA in a research note on Friday. Nine equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $2,015.43.

View Our Latest Stock Report on Comfort Systems USA

Comfort Systems USA Profile (Free Report)

Comfort Systems USA, Inc is a U.S.-based mechanical contracting company that provides a range of heating, ventilation and air conditioning (HVAC) services to commercial, industrial and institutional customers. The company focuses on the design, installation, maintenance and repair of HVAC systems, and it supports projects from initial engineering and system selection through long-term service agreements and upgrades.

Its service offerings include new construction and retrofit installations, preventive and corrective maintenance, emergency repair, energy management and building automation systems.

Featured Articles Five stocks we like better than Comfort Systems USA The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Comfort Systems USA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Comfort Systems USA and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBaader Bank Aktiengesellschaft Makes New Investment in Cloudflare, Inc. $NET

NEXT HEADLINE »Western Digital Corporation $WDC Shares Bought by Baader Bank Aktiengesellschaft

Posted by Defense World Staff on Jul 21st, 2026

Bank of New York Mellon Corp raised its stake in Aramark (NYSE:ARMK – Free Report) by 4.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,558,199 shares of the company’s stock after acquiring an additional 114,662 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.97% of Aramark worth $103,709,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Bleakley Financial Group LLC bought a new position in Aramark during the first quarter valued at $412,000. State of Michigan Retirement System lifted its position in shares of Aramark by 1.8% during the 1st quarter. State of Michigan Retirement System now owns 63,200 shares of the company’s stock valued at $2,562,000 after buying an additional 1,100 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Aramark by 3.8% during the 1st quarter. Principal Financial Group Inc. now owns 586,473 shares of the company’s stock worth $23,776,000 after acquiring an additional 21,267 shares during the period. Chicago Partners Investment Group LLC increased its holdings in Aramark by 26.1% in the 1st quarter. Chicago Partners Investment Group LLC now owns 11,620 shares of the company’s stock worth $471,000 after acquiring an additional 2,406 shares during the last quarter. Finally, Procyon Advisors LLC raised its stake in Aramark by 5.3% in the 1st quarter. Procyon Advisors LLC now owns 10,590 shares of the company’s stock valued at $429,000 after acquiring an additional 532 shares during the period.

Analysts Set New Price Targets A number of research firms recently weighed in on ARMK. The Goldman Sachs Group reiterated a “buy” rating and issued a $51.00 price objective on shares of Aramark in a research note on Wednesday, May 13th. Robert W. Baird raised their price target on Aramark from $50.00 to $58.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Stifel Nicolaus lifted their price target on Aramark from $47.00 to $54.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. UBS Group reiterated a “buy” rating and set a $67.00 price objective on shares of Aramark in a research note on Monday, July 13th. Finally, Royal Bank Of Canada increased their price objective on Aramark from $47.00 to $55.00 and gave the stock an “outperform” rating in a report on Thursday, May 14th. Eleven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $59.21.

View Our Latest Stock Analysis on ARMK

Aramark Price Performance Shares of Aramark stock opened at $56.52 on Tuesday. Aramark has a 52-week low of $35.07 and a 52-week high of $58.68. The stock has a market capitalization of $14.86 billion, a price-to-earnings ratio of 42.18, a price-to-earnings-growth ratio of 1.08 and a beta of 1.11. The company has a fifty day moving average of $54.31 and a 200-day moving average of $45.67. The company has a debt-to-equity ratio of 1.85, a quick ratio of 1.07 and a current ratio of 1.21.

Aramark (NYSE:ARMK – Get Free Report) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.75 billion. Aramark had a return on equity of 17.05% and a net margin of 1.84%.Aramark’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same period last year, the company earned $0.35 EPS. Aramark has set its FY 2026 guidance at 2.180-2.280 EPS. Equities research analysts expect that Aramark will post 2.24 EPS for the current year.

Aramark Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Wednesday, June 3rd. Stockholders of record on Wednesday, May 20th were issued a $0.12 dividend. The ex-dividend date was Wednesday, May 20th. This represents a $0.48 annualized dividend and a dividend yield of 0.8%. Aramark’s dividend payout ratio (DPR) is currently 35.82%.

Aramark Profile (Free Report)

Aramark (NYSE: ARMK) is a global provider of food services, facilities management and uniform solutions, serving clients across a wide array of industries including education, healthcare, business and government. The company operates through three primary segments: Food and Support Services, Uniform and Career Apparel, and Facility Services, delivering integrated solutions designed to enhance guest experiences, improve operational efficiencies and maintain safe, clean environments. Aramark’s offerings include corporate dining, patient and senior nutrition, campus dining, sports and entertainment concessions, custodial services, technical maintenance and industrial laundry.

Founded in 1959 and headquartered in Philadelphia, Pennsylvania, Aramark has expanded its footprint to more than 20 countries, with a strong presence in North America, Latin America, Europe and Asia.

Featured Articles Five stocks we like better than Aramark The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Aramark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aramark and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBaader Bank Aktiengesellschaft Has $2.65 Million Position in Heico Corporation $HEI

NEXT HEADLINE »Bank of New York Mellon Corp Sells 40,961 Shares of American Financial Group, Inc. $AFG

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Peabody Energy To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Peabody Energy between October 14, 2024 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - July 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Peabody Energy Corporation ("Peabody Energy" or the "Company") (NYSE: BTU) and reminds investors of the August 24, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Peabody Energy's Centurion mine and the multitude of issues causing delays to the ramp-up and the return to full longwall production dates. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Peabody Energy's securities at artificially inflated prices.

On March 30, 2026, Peabody Energy issued a press release lowering guidance pertaining to Centurion mine's expected first quarter 2026 output, announcing that sales volume from the Centurion mine was expected to deliver approximately 250,000 tons in the first quarter due to "greater-than-anticipated mine commissioning challenges" (compared to previous estimates of around 700,000 tons). On this news, Peabody Energy's stock price fell $3.82, or approximately 9.7%, to close at $35.68 per share on March 30, 2026.

On May 5, 2026, Peabody Energy issued a press release disclosing the Company's failure to ramp-up Centurion by the long-awaited March 2026 deadline and cutting guidance related to full year met segment volumes to reflect the increased cost and substantial volume decrease, reducing the full year sales outlook for Centurion to 2.5 million tons compared to the original expectation of 3.5 million tons. On this news, Peabody Energy's stock price fell $1.52, or 5.7%, to close at $25.00 per share on May 5, 2026.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Peabody Energy's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Peabody Energy class action, go to www.faruqilaw.com/BTU or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Peabody Energy Securities Class Action Lawsuit:

What is the Peabody Energy securities fraud lawsuit about?

The lawsuit alleges that Peabody Energy Corporation (NYSE: BTU) and certain of its officers and directors made materially false and misleading statements and/or concealed material adverse facts concerning the true condition of the Company's Centurion mine, including the nature and severity of issues allegedly causing delays to its ramp-up and return to full longwall production. The complaint alleges that, throughout the Class Period, defendants provided investors with overwhelmingly positive statements about the Centurion mine while purportedly withholding information about the multitude of operational challenges affecting it. These allegedly false and misleading statements are said to have caused investors to purchase Peabody Energy securities at artificially inflated prices. The inflation in the stock price allegedly began to correct when Peabody Energy disclosed, on March 30, 2026, that first quarter 2026 output from the Centurion mine was expected to reach only approximately 250,000 tons — well below prior estimates of approximately 700,000 tons — due to "greater-than-anticipated mine commissioning challenges," and further when the Company disclosed on May 5, 2026 that it had failed to ramp up the mine by its March 2026 deadline and cut its full-year sales outlook for Centurion from 3.5 million tons to 2.5 million tons.

Who may be eligible to participate in the lawsuit?

Investors who purchased or otherwise acquired Peabody Energy Corporation (NYSE: BTU) securities on the NASDAQ between October 14, 2024 and May 4, 2026, inclusive, may be eligible to participate in this lawsuit as members of the proposed class. Eligibility to participate is not limited to investors who seek appointment as lead plaintiff; any qualifying class member may share in any recovery that may ultimately be obtained. Investors who purchased Peabody Energy securities during the Class Period and suffered losses are encouraged to review their transaction records to determine whether they fall within the defined class. Participation in a class action does not require that an investor take any individual legal action or incur separate legal fees to potentially benefit from any recovery achieved on behalf of the class.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff is a court-appointed representative who acts on behalf of all class members in directing the litigation, including making key decisions regarding litigation strategy and the selection of lead counsel. Any class member who purchased Peabody Energy securities during the Class Period and suffered a loss may move the court for appointment as lead plaintiff, and courts typically appoint the movant with the largest financial interest in the outcome of the litigation who otherwise satisfies applicable legal requirements. The deadline to file a motion seeking appointment as lead plaintiff is August 24, 2026. Importantly, investors are not required to seek appointment as lead plaintiff in order to participate in the class and share in any recovery that may result from the litigation — class members who do not serve as lead plaintiff retain the ability to benefit from any settlement or judgment.

What should investors do if they purchased Peabody Energy stock during the Class Period?

Investors who purchased Peabody Energy Corporation (NYSE: BTU) securities between October 14, 2024 and May 4, 2026, inclusive, are encouraged to promptly review their brokerage records and account statements to confirm the dates and prices at which they acquired and, if applicable, sold their shares. Investors should take steps to preserve all relevant documentation, including transaction confirmations, account statements, and any communications relating to their Peabody Energy holdings, as such records may be relevant to establishing eligibility and calculating losses. Given that the lead plaintiff motion deadline is August 24, 2026, investors wishing to be considered for appointment as lead plaintiff should act well in advance of that date. Investors may wish to consult with Faruqi & Faruqi, LLP or other qualified securities counsel to evaluate their legal rights and options before the deadline.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Peabody Energy securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305847

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

July 21, 2026 08:30 ET  | Source: InterDigital, Inc.

WILMINGTON, Del., July 21, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company, today announced that the company has signed a new patent license agreement with KEBA Energy Automation GmbH.

The agreement covers certain KEBA EV charger products under InterDigital’s global patent portfolio related to the 3G, 4G and Wi-Fi standards.

“This license reflects the expansion of connectivity into new verticals and demonstrates KEBA’s recognition of the value our innovation brings to products in the Internet of Things,” commented Julia Mattis, Chief Licensing Officer, InterDigital. “We expect to see continued licensing momentum as more manufacturers implement our technology across new device categories in the IoT market.”

About InterDigital®

InterDigital is a global research and development company focused primarily on wireless, video, artificial intelligence (“AI”), and related technologies. We design and develop foundational technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. We license our innovations worldwide to companies providing such products and services, including makers of wireless communications devices, consumer electronics, IoT devices, cars and other motor vehicles, and providers of cloud-based services such as video streaming. As a leader in wireless technology, our engineers have designed and developed a wide range of innovations that are used in wireless products and networks, from the earliest digital cellular systems to 5G and today’s most advanced Wi-Fi technologies. We are also a leader in video processing and video encoding/decoding technology, with a significant AI research effort that intersects with both wireless and video technologies. Founded in 1972, InterDigital is listed on Nasdaq.

InterDigital is a registered trademark of InterDigital, Inc.

For more information, visit: www.interdigital.com.

InterDigital Contact:
Richard Lloyd
Email: [email protected]
+1 (202) 349-1716

Goldman Sachs, on July 14, posted upbeat earnings for the second quarter. The firm reported earnings of $20.98 per share, well above the analyst consensus estimate of $14.40. Net revenue increased 39% year over year to $20.34 billion, beating the consensus estimate of $16.13 billion, driven by strength in its Global Banking & Markets business.

Don’t forget to check out our premarket coverage here

DCLA’s Sarat Sethi named Morgan Stanley (NYSE:MS) as his final trade.

Morgan Stanley, on July 15, reported upbeat earnings for the second quarter. The company posted quarterly earnings of $3.46 per share which beat the analyst consensus estimate of $2.91 per share. The company reported quarterly sales of $21.348 billion which beat the analyst consensus estimate of $19.637 billion.

Shannon Saccocia, chief investment officer – Wealth for Neuberger, recommended iShares U.S. Energy ETF (NYSE:IYE).

Joseph M. Terranova, senior managing director for Virtus Investment Partners, named Valero Energy Corporation (NYSE:VLO).

As per the recent news, Valero Energy, on July 16, declared a regular quarterly cash dividend of $1.20 per share and authorized an additional $5 billion share repurchase program.

Price Action Morgan Stanley shares fell 2.1% to close at $210.94 on Monday. Goldman Sachs shares fell 0.6% to settle at $90.15 during the session. iShares U.S. Energy ETF gained 0.5% on Monday. Valero Energy shares gained 1.2% to close at $313.31 on Monday. Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Logitech (SIX: LOGN) (NASDAQ: LOGI) today announced progress against its sustainability goals with the release of its [url="]Fiscal Year 2026 Impact Highlights

Posted by Defense World Staff on Jul 21st, 2026

California Public Employees Retirement System boosted its holdings in shares of Ulta Beauty Inc. (NASDAQ:ULTA – Free Report) by 10.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 91,187 shares of the specialty retailer’s stock after purchasing an additional 8,523 shares during the period. California Public Employees Retirement System owned about 0.21% of Ulta Beauty worth $47,664,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the business. Kera Capital Partners Inc. lifted its holdings in shares of Ulta Beauty by 7.6% in the 1st quarter. Kera Capital Partners Inc. now owns 1,679 shares of the specialty retailer’s stock valued at $878,000 after buying an additional 119 shares during the period. Assetmark Inc. grew its holdings in Ulta Beauty by 44.9% during the first quarter. Assetmark Inc. now owns 371 shares of the specialty retailer’s stock worth $194,000 after acquiring an additional 115 shares during the period. Gallacher Capital Management LLC acquired a new stake in Ulta Beauty during the first quarter worth about $235,000. Angeles Wealth Management LLC raised its position in Ulta Beauty by 6.2% during the first quarter. Angeles Wealth Management LLC now owns 891 shares of the specialty retailer’s stock valued at $466,000 after acquiring an additional 52 shares in the last quarter. Finally, Avalon Trust Co raised its position in Ulta Beauty by 1.9% during the first quarter. Avalon Trust Co now owns 2,833 shares of the specialty retailer’s stock valued at $1,481,000 after acquiring an additional 52 shares in the last quarter. 90.39% of the stock is owned by hedge funds and other institutional investors.

Insider Activity In related news, Director George R. Mrkonic, Jr. sold 383 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $475.84, for a total value of $182,246.72. Following the completion of the transaction, the director directly owned 2,404 shares of the company’s stock, valued at $1,143,919.36. This represents a 13.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.20% of the company’s stock.

Ulta Beauty Trading Up 1.8% Ulta Beauty stock opened at $488.08 on Tuesday. The company has a 50-day moving average price of $477.84 and a 200 day moving average price of $562.08. Ulta Beauty Inc. has a 12-month low of $443.60 and a 12-month high of $714.97. The stock has a market cap of $20.98 billion, a P/E ratio of 18.30, a PEG ratio of 1.50 and a beta of 0.88.

Ulta Beauty (NASDAQ:ULTA – Get Free Report) last announced its quarterly earnings results on Tuesday, June 2nd. The specialty retailer reported $7.74 EPS for the quarter, beating the consensus estimate of $6.89 by $0.85. Ulta Beauty had a return on equity of 44.77% and a net margin of 9.36%.The business had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.12 billion. During the same quarter in the prior year, the company posted $6.70 EPS. The company’s quarterly revenue was up 11.1% on a year-over-year basis. Ulta Beauty has set its FY 2026 guidance at 28.360-28.800 EPS. As a group, analysts forecast that Ulta Beauty Inc. will post 28.76 EPS for the current year.

Analyst Ratings Changes ULTA has been the subject of several research analyst reports. DA Davidson reduced their target price on Ulta Beauty from $650.00 to $585.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Robert W. Baird dropped their price target on shares of Ulta Beauty from $730.00 to $700.00 and set an “outperform” rating on the stock in a research note on Wednesday, June 3rd. Citigroup cut their price target on shares of Ulta Beauty from $600.00 to $560.00 and set a “neutral” rating for the company in a report on Thursday, June 4th. Evercore set a $635.00 price objective on shares of Ulta Beauty in a research report on Wednesday, June 3rd. Finally, Wedbush started coverage on shares of Ulta Beauty in a report on Monday, April 20th. They set an “outperform” rating on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $638.09.

View Our Latest Research Report on Ulta Beauty

Ulta Beauty Company Profile (Free Report)

Ulta Beauty, Inc (NASDAQ: ULTA) is a U.S.-based specialty retailer and beauty services provider focused on cosmetics, fragrance, skin care, hair care, bath and body, and beauty tools. The company operates a dual-format business that combines brick-and-mortar retail stores with an e-commerce platform, offering a broad assortment of national, prestige and mass-market brands alongside its own private-label products. In many locations Ulta also provides full-service salon treatments, positioning the company as a one-stop destination for product discovery and in-store services.

The retailer’s product mix spans color cosmetics, haircare and styling products, skin and body care, fragrance, and accessories, catering to a wide range of consumer preferences and price points.

Read More Five stocks we like better than Ulta Beauty The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Ulta Beauty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ulta Beauty and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Sells 27,814 Shares of Constellation Brands Inc $STZ

NEXT HEADLINE »California Public Employees Retirement System Has $48.22 Million Holdings in Texas Pacific Land Corporation $TPL

HOUSTON, July 21, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a regional agreement with Medical Mutual effective July 1, 2026, covering approximately 1.2 million people throughout Ohio and Kentucky, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) assay. This brings CNSide CSF TCE assay total contracted coverage to approximately 127 million people.

The CNSide® CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases. The superior clinical utility of CNSide® over standard of care has been shown in 11 peer-reviewed publications, the FORESEE clinical trial, and has been validated in the market through real-world use.

More than 11,000 CNSide® tests have been performed at over 120 U.S. cancer institutions since 2020, delivering high sensitivity (92%) and specificity (95%), while influencing treatment decisions in 90% of cases.

This test is available exclusively through CNSide Diagnostics, LLC. as a testing service provided to health care professionals in the U.S.

About CNSide Diagnostics, LLC
CNSide Diagnostics, LLC, a wholly owned subsidiary of Plus Therapeutics, Inc., develops and commercializes proprietary laboratory-developed tests such as CNSide®, which is designed to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The CNSide® CSF Assay Platform enables quantitative analysis of cerebrospinal fluid to inform and improve the management of patients with leptomeningeal metastases. For more information, please visit www.cnside-dx.com.

About Plus Therapeutics
Plus Therapeutics, Inc. (NASDAQ: PSTV) is a clinical-stage healthcare company advancing an integrated approach to central nervous system (“CNS”) cancers through precision therapeutics, molecular diagnostics and data-driven technologies. The Company's lead therapeutic platform, REYOBIQ™ (rhenium Re186 obisbemeda), is being developed for the treatment of leptomeningeal metastases, recurrent glioblastoma and pediatric brain cancers. Its CNSide® cerebrospinal fluid assay platform is designed to provide diagnostic and disease monitoring information to support the management of patients with CNS cancers. Together with its growing data and artificial intelligence capabilities, Plus Therapeutics is building an integrated CNS oncology platform intended to improve clinical decision-making, accelerate therapeutic development and advance personalized care for patients with CNS cancers.

Effective August 3, 2026, Plus Therapeutics will change its corporate name to Cerenome, Inc. and begin trading under the Nasdaq ticker symbol CNSY. Until that date, the Company will continue to operate as Plus Therapeutics and trade under the ticker symbol PSTV.

For more information, please visit www.plustherapeutics.com. Beginning August 3, 2026, additional information will be available at www.cerenome.com.

About Medical Mutual

Founded in 1934, Medical Mutual is the oldest and one of the largest health insurance companies based in Ohio. We provide peace of mind to more than 1.2 million members through our high-quality health, life, disability, dental, vision and indemnity plans. We offer fully insured and self-funded group coverage, including stop loss, as well as Medicare Advantage, Medicare Supplement, and individual plans. For more information, please visit http://www.medicalmutual.com/.

Forward-Looking Statements
This press release contains statements that may be deemed “forward-looking statements” within the meaning of U.S. securities laws, including statements regarding clinical trials, expected operations and upcoming developments. All statements in this press release other than statements of historical fact are forward-looking statements. These forward-looking statements may be identified by future verbs, as well as terms such as “expect,” “potential,” “anticipating,” “planning” and similar expressions or the negatives thereof. Such statements are based upon certain assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These statements include, without limitation, statements regarding the potential market for the CNSide CSF Assay, the timing in which the CNSide CSF Assay is commercially launched and commercialization is expanded, revenue and corporate profitability expectations including support reimbursements and payments for the CNSide CSF Assay, the development and utility of the CNSide CSF Assay and expectations as to the Company’s future performance, including the next steps in developing the Company’s product candidates.

Investor Contact
CORE IR
[email protected]

Posted by Defense World Staff on Jul 21st, 2026

California Public Employees Retirement System lowered its stake in Copart, Inc. (NASDAQ:CPRT – Free Report) by 4.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,551,171 shares of the business services provider’s stock after selling 66,828 shares during the quarter. California Public Employees Retirement System owned 0.16% of Copart worth $51,499,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Quadrant Capital Group LLC lifted its holdings in Copart by 1.3% during the third quarter. Quadrant Capital Group LLC now owns 20,693 shares of the business services provider’s stock valued at $931,000 after purchasing an additional 264 shares in the last quarter. Sierra Legacy Group lifted its stake in Copart by 1.9% in the 4th quarter. Sierra Legacy Group now owns 13,880 shares of the business services provider’s stock valued at $543,000 after buying an additional 265 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in Copart by 23.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 1,384 shares of the business services provider’s stock valued at $68,000 after buying an additional 266 shares in the last quarter. Brown Miller Wealth Management LLC boosted its holdings in Copart by 3.8% in the 4th quarter. Brown Miller Wealth Management LLC now owns 7,310 shares of the business services provider’s stock worth $286,000 after buying an additional 268 shares during the last quarter. Finally, Valeo Financial Advisors LLC boosted its holdings in Copart by 4.6% in the 4th quarter. Valeo Financial Advisors LLC now owns 6,395 shares of the business services provider’s stock worth $250,000 after buying an additional 282 shares during the last quarter. Hedge funds and other institutional investors own 85.78% of the company’s stock.

Copart Trading Down 0.4% Shares of NASDAQ CPRT opened at $27.49 on Tuesday. The company has a 50-day moving average of $30.61 and a 200 day moving average of $34.36. Copart, Inc. has a 12-month low of $27.18 and a 12-month high of $50.11. The stock has a market cap of $25.45 billion, a PE ratio of 17.07 and a beta of 1.02.

Copart (NASDAQ:CPRT – Get Free Report) last issued its earnings results on Thursday, May 21st. The business services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.02. Copart had a return on equity of 16.63% and a net margin of 33.48%.The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.19 billion. During the same period in the previous year, the firm posted $0.42 EPS. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, sell-side analysts forecast that Copart, Inc. will post 1.58 EPS for the current fiscal year.

Analysts Set New Price Targets A number of equities analysts have commented on CPRT shares. Freedom Capital raised Copart to a “strong-buy” rating in a report on Friday, June 26th. Jefferies Financial Group set a $45.00 price target on Copart in a research note on Friday, May 22nd. Weiss Ratings cut Copart from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 1st. Finally, Zacks Research raised Copart from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Three equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $44.50.

Read Our Latest Analysis on Copart

Copart Profile (Free Report)

Copart (NASDAQ: CPRT) is a global provider of online vehicle auction and remarketing services, focused primarily on the sale of salvage and clean-title vehicles. The company operates a technology-driven auction platform that connects sellers — including insurance companies, vehicle finance firms, rental car companies, dealerships and fleet owners — with a broad buyer base consisting of vehicle dismantlers, recyclers, rebuilders and retail buyers. Copart’s business model centers on efficient vehicle disposition using digital bidding and logistics services to maximize recovery value for its clients.

Core services include hosting live and timed online auctions, vehicle listing and inspection support, title processing, and transportation and storage solutions.

See Also Five stocks we like better than Copart The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Copart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Copart and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE6,723 Shares in Broadcom Inc. $AVGO Purchased by Brown Shipley& Co Ltd

NEXT HEADLINE »California Public Employees Retirement System Has $51.32 Million Holdings in Iron Mountain Incorporated $IRM

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 4, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 third quarter ended June 30, 2026.Webcast and Conference Call DetailsInvestors may access a live audio webcast on the Events and Presentations page under the Investors section of the Arrowhead website. A replay of the webcast will be available approximately two hour.

Posted by Defense World Staff on Jul 21st, 2026

Baader Bank Aktiengesellschaft decreased its position in Amphenol Corporation (NYSE:APH – Free Report) by 50.3% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 9,159 shares of the electronics maker’s stock after selling 9,254 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Amphenol were worth $1,135,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Vermillion & White Wealth Management Group LLC boosted its holdings in Amphenol by 163.8% during the fourth quarter. Vermillion & White Wealth Management Group LLC now owns 182 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 113 shares during the last quarter. Riggs Asset Managment Co. Inc. grew its position in Amphenol by 200.0% in the second quarter. Riggs Asset Managment Co. Inc. now owns 252 shares of the electronics maker’s stock valued at $25,000 after purchasing an additional 168 shares in the last quarter. Tucker Asset Management LLC acquired a new stake in Amphenol in the 4th quarter valued at $26,000. HHM Wealth Advisors LLC acquired a new stake in Amphenol in the 1st quarter valued at $27,000. Finally, Lloyd Advisory Services LLC. bought a new stake in Amphenol during the 4th quarter worth about $29,000. Institutional investors and hedge funds own 97.01% of the company’s stock.

Insider Buying and Selling at Amphenol In related news, CEO Richard Adam Norwitt sold 61,072 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $143.90, for a total value of $8,788,260.80. Following the sale, the chief executive officer owned 1,927,507 shares in the company, valued at approximately $277,368,257.30. This represents a 3.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last quarter, insiders sold 130,775 shares of company stock worth $18,709,350. 1.42% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth A number of research firms have recently commented on APH. Evercore restated an “outperform” rating on shares of Amphenol in a research note on Wednesday, May 27th. Citigroup reiterated a “buy” rating and set a $195.00 target price (up from $180.00) on shares of Amphenol in a report on Monday, July 13th. Rothschild & Co Redburn increased their price target on Amphenol from $160.00 to $172.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. The Goldman Sachs Group raised their price target on Amphenol from $184.00 to $201.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Finally, TD Cowen reaffirmed a “hold” rating and set a $175.00 price target (up from $135.00) on shares of Amphenol in a research report on Monday, July 13th. Fourteen research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $186.00.

View Our Latest Stock Analysis on Amphenol

Amphenol Trading Down 0.5% Shares of NYSE:APH opened at $150.50 on Tuesday. Amphenol Corporation has a 52-week low of $95.19 and a 52-week high of $178.52. The company has a market capitalization of $185.15 billion, a P/E ratio of 43.25, a price-to-earnings-growth ratio of 1.29 and a beta of 1.24. The company has a 50-day simple moving average of $150.36 and a 200 day simple moving average of $144.16. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.71.

Amphenol (NYSE:APH – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The electronics maker reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.11. The firm had revenue of $7.62 billion for the quarter, compared to the consensus estimate of $7.08 billion. Amphenol had a return on equity of 37.44% and a net margin of 17.24%.The business’s revenue was up 58.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.63 earnings per share. Amphenol has set its Q2 2026 guidance at 1.140-1.160 EPS. Sell-side analysts forecast that Amphenol Corporation will post 4.87 earnings per share for the current year.

Amphenol Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Tuesday, June 23rd were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Tuesday, June 23rd. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.7%. Amphenol’s payout ratio is presently 28.74%.

Amphenol Company Profile (Free Report)

Amphenol Corporation (NYSE: APH) is a leading global manufacturer of electronic and fiber optic connectors, interconnect systems, and related components. The company designs, engineers and produces a broad range of products including electrical connectors, cable assemblies, fiber optic solutions, sensors, antennas and electromechanical devices used to transfer power, signal and data across complex systems. Its product portfolio spans ruggedized connectors for harsh environments to high-speed solutions for data centers and telecommunications networks.

Amphenol serves a diverse set of end markets, including automotive, broadband and telecom, data communications, mobile devices, industrial, energy, and military/aerospace.

See Also Five stocks we like better than Amphenol The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding APH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amphenol Corporation (NYSE:APH – Free Report).

Receive News & Ratings for Amphenol Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amphenol and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBalefire LLC Lowers Stock Holdings in Oracle Corporation $ORCL

NEXT HEADLINE »Fifth Third Bancorp Has $1.44 Billion Stock Holdings in Alphabet Inc. $GOOGL

Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Timken Company (NYSE: TKR; www.timken.com), a leader in advanced motion technology, will release its 2026 second-quarter financial results on Tuesday, August 4, prior to the opening of the New York Stock Exchange. The company will host a conference call that day to discuss its financial performance with investors and securities analysts. The financial results and conference call materials will be available online at http://investors.timken.com.

Conference Call: 

Timken's Q2 2026 Earnings Results

Tuesday, August 4, 2026

11:00 a.m. Eastern Time

Live Dial-In: 1-888-880-3330

Conference ID: 2764753    

Live Webcast: 

http://investors.timken.com

Register in Advance:       

https://tmkn.biz/4b21FiY

Replay:  

https://tmkn.biz/4b21FiY

About The Timken Company
The Timken Company (NYSE: TKR; www.timken.com), a leader in advanced motion technology, designs and manufacturers highly engineered systems and components for customers in strategic end markets, including aerospace and defense, power and electrification, and automation and industrial solutions. With more than 125 years of specialized expertise and a multinational presence, Timken is a trusted partner worldwide, innovating and powering performance across the application lifecycle. The company posted $4.6 billion in sales in 2025 and employs approximately 19,000 people, operating from 45 countries. Learn more at www.timken.com or @TheTimkenCompany.

Media Relations:
Sarah Factor
234.262.4878
[email protected]

Investor Relations:
Neil Frohnapple
234.262.2310
[email protected] 

SOURCE The Timken Company

Also from this source

With a more than 8% yield, Western Midstream Partners (WES +1.39%) should be hard to ignore. However, it doesn't have as much positive coverage on Wall Street as other master limited partnerships (MLPs). As a result, it's flying under the radar of most investors.

Here's a look at why you won't want to ignore this high-yielding MLP.

Image source: Getty Images.

Underfollowed and unloved Fourteen Wall Street analysts currently cover Western Midstream Partners. Only four have a "buy" rating on the MLP, while nine rate it a "hold" and one has a "sell" rating. For comparison, 21 analysts currently cover both Energy Transfer (ET 0.20%) and Enterprise Products Partners (EPD +1.52%). They're very bullish on Energy Transfer (five "strong buys" and 14 "buy" ratings) and moderately bullish on Enterprise Products Partners (two "strong buys" and eight "buys").

There are many reasons fewer analysts cover this MLP. It's not as big or as diversified as Energy Transfer or Enterprise Products Partners. Western Midstream also has significant ties to one company: Occidental Petroleum. The oil giant is its top unitholder (39.5% of its common units) and largest customer (55% of its revenue in 2025, falling to 47% in 2026). These and other factors are leading some Wall Street analysts to completely ignore the company.

Today's Change

(

1.39

%) $

0.64

Current Price

$

46.61

What Wall Street is missing For the most part, Wall Street analysts focus on growth over income. As a result, they tend to miss out on the total return potential of some higher-yielding stocks.

Western Midstream's base return comes from its high-yielding distribution. At over 8%, the MLP offers a higher cash yield than Enterprise Products Partners (5.8% current yield) and Energy Transfer (6.6%). That high-yielding payout is on a rock-solid foundation. It generates stable cash flows backed by long-term, fee-based contracts with Occidental Petroleum and third-party customers. The MLP currently expects to produce between $1.9 billion and $2.1 billion of distributable cash flow this year, easily covering its $1.5 billion annual distribution outlay. It also has a solid investment-grade balance sheet backed by a low 3.1 times leverage ratio.

That gives the MLP the financial flexibility to grow its operations through bolt-on acquisitions and organic growth capital projects. The company recently closed its $1.6 billion acquisition of Brazos Delaware, which strategically expands its operations in a core area, further diversifies its revenue away from Occidental, while immediately boosting its cash flow per unit. The MLP also has several organic expansion projects underway, including the Loving II gas processing plant and Pathfinder Pipeline, both of which will enter commercial service early next year. Western expects its growth drivers to fuel long-term adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) growth of 4% to 5% per year. That should support continued annual distribution growth in the low-to-mid single-digits.

High-octane total return potential Western Midstream's high-yielding distribution provides an over 8% base cash return each year, which should grow at a low-to-mid single-digit rate. The company's earnings and distribution growth should support a steadily rising unit price. Add it up, and the MLP could deliver an annual total return of 12% to 14%. That's an attractive proposition for investors comfortable with receiving the Schedule K-1 Federal tax form the MLP sends each year.

Matt DiLallo has positions in Energy Transfer and Enterprise Products Partners. The Motley Fool recommends Enterprise Products Partners and Occidental Petroleum. The Motley Fool has a disclosure policy.

Posted by Defense World Staff on Jul 21st, 2026

Assetmark Inc. raised its stake in ITT Inc. (NYSE:ITT – Free Report) by 6,323.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,434 shares of the conglomerate’s stock after purchasing an additional 40,789 shares during the period. Assetmark Inc.’s holdings in ITT were worth $7,894,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Andina Capital Management LLC grew its position in shares of ITT by 1.6% during the fourth quarter. Andina Capital Management LLC now owns 3,166 shares of the conglomerate’s stock worth $549,000 after buying an additional 49 shares in the last quarter. Kestra Private Wealth Services LLC raised its holdings in ITT by 2.8% in the first quarter. Kestra Private Wealth Services LLC now owns 1,942 shares of the conglomerate’s stock valued at $370,000 after acquiring an additional 52 shares in the last quarter. Whittier Trust Co. lifted its stake in ITT by 5.1% in the first quarter. Whittier Trust Co. now owns 1,064 shares of the conglomerate’s stock worth $207,000 after acquiring an additional 52 shares during the last quarter. Toronto Dominion Bank increased its position in shares of ITT by 2.2% in the 4th quarter. Toronto Dominion Bank now owns 2,481 shares of the conglomerate’s stock valued at $430,000 after purchasing an additional 53 shares during the last quarter. Finally, Stephens Inc. AR increased its position in shares of ITT by 3.8% in the 4th quarter. Stephens Inc. AR now owns 1,654 shares of the conglomerate’s stock valued at $287,000 after purchasing an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Analyst Ratings Changes Several equities research analysts have recently issued reports on ITT shares. Wall Street Zen cut shares of ITT from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. KeyCorp raised their price target on ITT from $230.00 to $250.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Robert W. Baird set a $246.00 price objective on ITT in a research report on Thursday, May 7th. Citigroup increased their price objective on ITT from $252.00 to $254.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, DA Davidson raised their target price on ITT from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Eleven equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $234.75.

View Our Latest Report on ITT

ITT Price Performance Shares of NYSE:ITT opened at $191.18 on Tuesday. ITT Inc. has a one year low of $155.58 and a one year high of $225.26. The stock has a market capitalization of $17.09 billion, a price-to-earnings ratio of 33.72, a PEG ratio of 1.81 and a beta of 1.27. The company has a 50-day simple moving average of $193.49 and a 200-day simple moving average of $195.21. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.01 and a current ratio of 1.53.

ITT (NYSE:ITT – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The conglomerate reported $1.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.21. The firm had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.12 billion. ITT had a return on equity of 16.83% and a net margin of 10.80%.The business’s revenue was up 32.7% on a year-over-year basis. During the same quarter last year, the company posted $1.45 earnings per share. ITT has set its FY 2026 guidance at 7.700-8.000 EPS. On average, analysts predict that ITT Inc. will post 7.91 EPS for the current year.

ITT Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Monday, July 6th. Shareholders of record on Monday, June 8th were paid a $0.386 dividend. This represents a $1.54 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Monday, June 8th. ITT’s dividend payout ratio (DPR) is 27.16%.

Insider Buying and Selling In other news, CAO Mesa Graziano Cheryl De sold 200 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $208.41, for a total value of $41,682.00. Following the transaction, the chief accounting officer owned 7,859 shares of the company’s stock, valued at approximately $1,637,894.19. The trade was a 2.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Lori B. Marino sold 7,123 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $208.27, for a total value of $1,483,507.21. Following the sale, the insider owned 8,729 shares of the company’s stock, valued at $1,817,988.83. This trade represents a 44.93% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.88% of the company’s stock.

ITT Profile (Free Report)

ITT Inc is a diversified industrial manufacturing company that designs, manufactures and services mission-critical components and systems for global markets. Its engineered solutions support applications in aerospace, defense, transportation, energy and industrial automation. The company focuses on delivering high-performance products that enable reliable fluid handling, precision motion control and robust connectivity in demanding environments.

The company’s operations are organized into three segments: Motion Technologies, which provides precision components and aftermarket repair services for aircraft engines and industrial turbines; Connect & Control Technologies, which offers specialty valves, couplings, seals and proximity sensors for fuel, hydraulics and environmental control systems; and Fluid & Motion Control, which delivers pumps, heat exchangers and fluid management solutions for oil and gas, chemical processing and power generation.

Recommended Stories Five stocks we like better than ITT The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding ITT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ITT Inc. (NYSE:ITT – Free Report).

Receive News & Ratings for ITT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITT and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAndra AP fonden Boosts Stock Position in Stryker Corporation $SYK

NEXT HEADLINE »Baader Bank Aktiengesellschaft Sells 3,022 Shares of Ferguson plc $FERG